Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclacel Pharmaceuticals

0.3700
-0.2350-38.84%
Post-market: 0.42000.0500+13.51%19:59 EDT
Volume:7.67M
Turnover:3.67M
Market Cap:8.79M
PE:-0.01
High:0.6600
Open:0.6051
Low:0.3528
Close:0.6050
Loading ...
Aug 16, 2022

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2022

Major Issues Report

8-K - Current report
Mar 30, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2022

Major Issues Report

8-K - Current report
Mar 16, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 15, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Major Issues Report

8-K - Current report
Aug 19, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2021

Major Issues Report

8-K - Current report